Recent research has gradually revealed that both aging and CD47 contribute to the development of MASLD/NASH by influencing glucolipid metabolic dysfunction, mitochondrial function, and hepatic sinusoidal homeostasis through several shared pathways (13, 22, 26). This evidence concerns the gene CD47 and metabolic dysfunction-associated steatohepatitis.